Dilantin-125 vs. Dilantin: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Dilantin-125 and Dilantin. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 63,355 people who take Dilantin-125 and Dilantin, and is updated regularly.
What is Dilantin-125?
Dilantin-125 has active ingredients of phenytoin. It is often used in epilepsy. eHealthMe is studying from 2,213 Dilantin-125 users. Check the latest studies of Dilantin-125.
What is Dilantin?
Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,858 Dilantin users. Check the latest studies of Dilantin.
63,355 people who take Dilantin-125 and Dilantin are studied.

Drugs being compared in this study:
- Dilantin-125 (phenytoin)
- Dilantin (phenytoin sodium)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Dilantin-125:
- not at all: 3.56 %
- somewhat: 12.1 %
- moderate: 17.44 %
- high: 32.03 %
- very high: 34.88 %
Dilantin:
- not at all: 2.54 %
- somewhat: 11.06 %
- moderate: 18.24 %
- high: 31.99 %
- very high: 36.17 %
Want to compare Dilantin-125 with Dilantin?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
- Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
- Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Dilantin-125 (2,127 reports)
- Dilantin (19,862 reports)
Browse all side effects of Dilantin-125:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dilantin:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on phenytoin and phenytoin sodium (the active ingredients of Dilantin-125 and Dilantin, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Purixan and Miralax - now
- Could Cannabis cause Hot Flushes Aggravated? - 6 seconds ago
- Catapres-Tts-1 vs. Catapres, side effect and effectiveness comparison - 10 seconds ago
- Could Vistaril cause Coronary Artery Disease Aggravated? - 45 seconds ago
- How effective is Daytrana for Narcolepsy? - 51 seconds ago
- Could Sulfasalazine cause Intervertebral Disc Disorder? - 56 seconds ago
- Could Haloperidol cause Rash Erythematous? - a minute ago
- Drug interactions of Demadex and Dynacirc - a minute ago
- Drug interactions of Clonidine and Letairis - a minute ago
- Could Omeprazole cause Hypokalemia? - a minute ago